Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2019-02-04

Clinical Trial Update: Trial of Autonomic neuroModulation for trEatment of Chronic Heart Failure [NA]

View source ↗

Summary

A clinical trial investigating autonomic neuromodulation for chronic heart failure sponsored by Abbott Medical Devices has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Abbott Medical Devices | Conditions: Heart Failure | NA | Status: WITHDRAWN